264. COVID-19 Associated Pulmonary Aspergillosis in Intensive Care Patients Based on Duration of Corticosteroid Administration

BACKGROUND: Coronavirus disease 2019 (COVID-19) associated pulmonary aspergillosis (CAPA) has emerged as a complication in critically ill COVID-19 patients. Corticosteroids are standard of care for COVID-19 patients. Prolonged corticosteroids have been associated with an increased risk of CAPA, but...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Meera D, Christina Gutierrez, G, Moote, Rebecca, Reveles, Kelly R, Hand, Elizabeth O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751639/
http://dx.doi.org/10.1093/ofid/ofac492.342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751639/
http://dx.doi.org/10.1093/ofid/ofac492.342

Ejemplares similares